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cc,-Antitrypsin has been isolated from liver inclusion bodies of a subject with a homozygous Z deficiency. 
The inhibitor was recovered in a fully active form by extraction in high salt at either pH 2.0 or pH 8.0. 
carbohydrate analysis indicated a protein in the ‘high mannose’ form, and this was collaborate by its sensi- 
tivity to endo-~~-~ucosaminidase. These data suggest hat the abnormal a,-antitrypsin is blocked in the 
secretory pathway prior to its entrance into the Golgi, and that this blockage is not due to a gross misfolding 
of the polypeptide. 
cr,-Antitrypsin Human liver Inclusion body 
1. INTRODUCTION 
rui-Antitrypsin (also known as cri-proteinase in- 
hibitor) is the major proteinase inhibitor in human 
plasma. It inhibits serine proteinases, including 
pancreatic elastase, trypsin, and chymotrypsin, as 
well as leukocyte proteinases. It is a glycoprotein 
with a molecular mass 52 kDa whose structure, 
function and abnormalities have been recently 
reviewed [I]. A deficiency of this inhibitor com- 
monly occurs in Europeans due to the presence of 
the 2 variant (342 Glu-Lys). The homozygous 
state (ZZ) for this variant results in a plasma con- 
centration of 15% of the normal MM genotype. 
This homozygous Z deficiency is associated with 
the development of pulmonary emphysema and 
hepatic cirrhosis [Z]. Individuals of this phenotype, 
as well as some who carry a single Z allele, have 
hepatic inclusions of PAS-positive, diastase- 
resistant globules which react with cui-antitrypsin 
antiserum [3,4]. Studies involving the material 
isolated from these inclusion bodies have 
demonstrated different carbohydrate structures 
from those observed with the secreted form IS]. 
Human liver was obtained as in [C;], stored at 
- 80°C until used, and the PAS-positive globular 
inclusion bodies isolated by a modification of a 
previously described method [3]. Briefly, portions 
of liver were pulverised while still frozen and in- 
cubated for 60 min at 37”C, with agitation in 
50 ml of Hank’s buffer containing 25 mg col- 
lagenase (Sigma, Grade IV). The suspension was 
filtered through a nylon gauze and centrifuged at 
3000 x g,, for 10 min at 4°C. The pellet was 
resuspended in 0.25 M sucrose containing 0.02% 
sodium azide at 4”C, and subjected to sonication 
for 30 s. It was then layered over a lO-40% 
sucrose gradient and centrifuged in a Beckman 
SW281 rotor for 2 h at 25000 x g,, and at 4°C. 
* On study leave from the Department of Biochemistry, The vesicles containing ai-antitrypsin were 
University of Georgia, Athens, GA 30602, USA pelleted by this procedure and were readily dis- 
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We have examined the oligosaccharide structure of 
the accumulated material to confirm that it is com- 
patible with a blockage of processing prior to entry 
to the Golgi. The inhibitory activity of the ac- 
cumulated material has also been measured to 
determine whether this blockage is due to a major 
alteration in polypeptide conformation. 
2. MATERIALS AND METHODS 
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solved in 0.125 M Tris (pH 6.8) containing 2% 
sodiumdode~ylsulphate, and 3% fl-mercaptoetha- 
nol. Protein content was determined using the 
Bradford assay [7], and ar-antitrypsin protein 
levels were measured by electroimmunoassay [8]. 
Endo-~-~glucos~inidase (Seikaghu Kogyo 
Co., Japan) was used to digest glycoprotein as in 
/16]. Protein molecular masses were determined by 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) in a lo-15% gel containing 0.2% SDS [9]. 
Protein transfer from the polyacrylamide gel to 
nitr~ellulose (Western blotting) was performed as 
in [IO]. Antisera and immuno reagents were pur- 
chased from Dako-immunoglobins (Copenhagen, 
Denmark), 
Carbohydrate analyses were performed on a 
Varian gas-liquid chromatograph as in [lo], l-3 ~1 
of the final silylated material was injected onto a 
column (180 x O.I6 cm i.d.) of 3% SE 30 and the 
chromatograph temperature programmed from 
125-225’C at l”C/min. Neutral and amino sugars 
were detected using flame ionization. 
The inhibitory activity of err-antitrypsin was 
followed by measuring the loss of elastase and 
trypsin esterase activity. Trypsin activity was 
measured using N-benzoyl-L-arginine ethyl ester 
[ 121 and elastase monitored with succinyl-tri-l- 
alanyl-p-nitroanilide 1131. 
3. RESULTS AND DISCUSSION 
Vesicles containing ai-antitrypsin were isolated 
from the liver of a patient previously phenotyped 
ZZ. The yield of vesicles was 240 f 20 mg/lO g 
fiver wet weight, with approximately ~~# of the 
totaf protein present as at-antitrypsin when 
measured by: (i) scanning of a Coomassie blue 
stained PAGE; and (ii) electroimmuno analysis. 
The tul-antitrypsin in these vesicles was readily 
soluble in the PAGE Ioading buffer containing 2% 
SDS and 3% ~-mer~aptoethanoI, but sparingty 
soluble in 8 M urea or 6 M guanidine 
hydrochloride. When SDS-PAGE was performed 
on the internal Z cYi-antitrypsin as well as the 
purified serum forms of Z and M (fig-la), the in- 
ternal liver form was found to have an apparent 
molecular mass of 55 kDa, lower than either of the 
two serum forms. Treatment with endo-@& 
ghrcosaminidase r sulted in a further reduction in 
molecular mass to 51 kDa, while the serum forms 
remained unaffected. This suggested that the band 
at 56 kDa was err-antitrypsin which had ac- 
cumulated in the liver vesicles as the ‘high man- 
nose’ form. This was confirmed by the technique 
of ‘Western blotting’, with only the most heavily 
staining band reacting with human ~~-antitr~sin 
antiserum (fig. I b). 
Analysis of the carbohydrate content of the 
purified serum and internal liver forms of 
al-antitrypsin was performed using gas-liquid 
chromatography. Using a series of internal stan- 
dards it was possible to both identify and quan- 
titate the individual sugars present. Table I shows 
that an identical composition was obtained for 
both the M and 2 serum forms of Lwr-antitrypsin 
while the Z internal farm was markedly different. 
There was a complete absence of sialic acid and N- 
a~etylgaIa~tose in the internaf Z, and a large in- 
crease in the mannose content. When these results 
are considered together with the endoglycosidase 
sensitivity, the evidence indicates that protein ac- 
cumulation must have occurred after core 
giycosylation in the endopiasmic reticulum, and 
prior to the high mannose ‘pruning’ which takes 
place in the Golgi. The limited number of glucose 
residues detected (table 1) suggests that some pro- 
cessing of the mannose-containing carbohydrate 
sidechains has occurred. The enzymes j3- 
glucosidase I and II known to be present in the 
rough endopIasmic reticulum could account for 
this processing fl4]. 
It has been reported [15] that the internal Z 
al-antitrypsin had no functional activity. How- 
ever, both the protein synthesised in vitro, either in 
a wheatgerm cell-free system (D.M. Errington, 
personal communisation) or in a reticulocyte iysate 
system using rat err-antitrypsin mRNA, and posses- 
sing the N-terminal, pre-protein extension [16], 
had readily detectable elastase inhibitory activity. 
To show that the material isolated from the liver 
vesicles was functionally active, we attempted to 
extract vesicles under non-denaturing conditions. 
Two methods were employed to isolate active in- 
hibitor, one involving extraction at neutral pH 
(50 mM Tris, pH 8.0, 0.5 M NaCl) and the second 
utilising acid conditions (50 mM acetate, pH 2.0, 
0.5 M NaCl). Plasma ~~-antitrypsi~ has been 
shown to retain biological activity under either of 
these conditions [17]. After 48 h extraction, 
solubilised cYr-antitrypsin was quantitated using 
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Fig. 1. Molecular mass comparisons of human err-antitrypsin M and Z serum form and Z internal form and the effect 
of treatment with endo-D-N-glucosaminidase. (A) Coomassie blue stained lo-15% polyacrylamide gel electrophoresis. 
Lane 1, molecular mass markers, from the top of the gel, phosphorylase B (95 kDa), bovine serum albumin (68 kDa), 
ovalbumin (45 kDa), carbonic anhydrase (30 kDa) and lysozyme (14.2 kDa); lane 2, M (serum form); lane 3, Z (serum 
form); lane 4,Z (internal form); lane 5, M (serum form) treated with endo-~-~-glucosaminidase; lane 6,Z (serum form) 
treated with endo-~-~-glucosaminidase; lane 7, Z (internal form) treated with endo-~-~-gIucosaminidase; lane 8, over- 
loading of endo-@-ZV-glucosaminidase. (B) Human cur-antitrypsin immunologically detected after Western blotting from 
SDS-PAGE. Lane 1, M (serum form); lane 2, M (serum form) endo-P-N-glucosaminidase treated; lane 3, Z (serum 
form); lane 4, 2 (serum form) endo-/Y-N-glucosaminidase treated; lane 5, Z (internal form); lane 6, Z (internal form) 
endo-B-N-glucosaminidase treated. 
electroimmunoassay. The extraction at pH 2.0 
yielded twice as much al-antitrypsin as that 
solubilised at pH 8.0. 
As shown in table 2, both extracts inhibited tryp- 
sin and elastase, with the specific activity of each 
being identical and equivalent to the Al-antitrypsin 
in normal serum. The specific activities for trypsin 
TIC (AAz5s/s per mg mr-antitrypsin) and elastase 
EIC (AA40ds per mg cul-antitrypsin) were: serum 
M (9.2 and 7.2, pH 2.0); Z (7.9 and 6.2, pH 8.0); 
and Z (10.8 and 8.7). This demonstrates that ex- 
tracted material functions normally despite the im- 
mature carbohydrate sidechains. The fact that the 
TIC/EIC ratio is normal indicates that the internal 
2 form is not oxidized at the active site 
methionine. 
Finally, it was possible to show that the Z inter- 
nal liver form bound elastase by subjecting the 
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Table 1 
Carbohydrate composition of human or-antitrypsin 
expressed as mole carbohydrate residue per mole protein 
assuming a molecular mass of 51 kDa and 12% 
carbohydrate for the serum form 
IV- Acetyl- 
M Z Z 
(serum) (serum) (liver) 
glucosamine 
Mannose 
Galactose 
N-Acetyl- 
12.3 11.9 6.8 
11.4 10.6 22.1 
7.1 6.3 0 
neuraminic acid 9.1 8.7 0 
Glucose 0 0 2.0 
complex to SDS-PAGE. [“‘I]Elastase was mixed 
with excess at-antitrypsin, boiled in gel loading 
buffer, and immediately loaded onto PAGE. The 
molecular mass of the iodinated elastase shifted 
from 24 kDa in the free form to 78 kDa in the 
complex form (fig.2), thus demonstrating that the 
elastase inhibitory activity was due to 
cur-antitrypsin and not a result of other con- 
taminating proteins. 
In summary, these results are compatible with a 
blockage in the transport of the protein prior to 
final processing in the Golgi vesicles. Our results 
support the observations that the Z internal liver 
form of cur-antitrypsin accumulates in the region of 
the endoplasmic reticulum. Since normal in- 
hibitory activity is retained in the high mannose 
Fig.2. Autoradiograph of [‘251)elastase complexed to 
excess serum and internal forms of Z human LYI 
antitrypsin. Lane 1, [‘*‘I]elastase with l/10 molar 
amount of M human ar-antitrypsin. The upper band 
(78 kDa) represents the complex, the lower (24 kDa) 
unreacted elastase; lane 2, Z (serum form); lane 3, Z 
(internal form) extracted at pH 2.0; lane 4, Z (internal 
form) extracted at pH 8.0. 
Table 2 
Determination of the functional activity of human ar-antitrypsin 
PH TIC EIC= TIC/EIC 
Internal cur-antitrypsin Z 
(83 mg/l) 
Internal ~,-antitrypsin Z 
(142 mgll) 
Serum cur-antitrypsin M 
(132 mg/l) 
8.0 1.80 1.44 1.25 
2.0 2.25 1.76 1.28 
2.42 1.89 1.28 
a Trypsin inhibitory capacity (TIC) was measured as AA&2000 s and elastase inhibitory 
capacity (EIC) as AA~~/2~0 s 
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form, the extracted ~~-antitr~s~n must be in its 
native form with the reactive centre in the intact, 
strained conformation [18]. This, therefore, ex- 
cludes the possibility that accumulation occurs due 
to a gross misfolding of the polypeptide chain. If 
the blockage at this step in secretion couId be over- 
come, then the secreted ~*-antitrypsin would be a 
fully effective inhibitor [19)* 
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